Sales rise 9.82% to Rs 1720.40 crore
Net profit of Jubilant Pharmova rose 7432.81% to Rs 482.10 crore in the quarter ended June 2024 as against Rs 6.40 crore during the previous quarter ended June 2023. Sales rose 9.82% to Rs 1720.40 crore in the quarter ended June 2024 as against Rs 1566.50 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var.Sales1720.401566.50 10 OPM %14.6210.74 -PBDT194.50114.90 69 PBT103.8025.20 312 NP482.106.40 7433Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
 "Pooja Khedkar IAS trainee")
 "Ultratech Cement")
 "Ashwini Vaishnaw, Ashwini, Vaishnaw, Railway minister")
 "ICAI CA 2024")
 "Microsoft, Microsoft logo")
